The TRP application process is NOW CLOSED.
Letters of Intent are currently under review.
The Translational Research Program puts you on the bench-to-bedside fast track when it comes to finding better treatment and cures for leukemia, lymphoma and myeloma. The Leukemia & Lymphoma Society funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application.
Translational Research Program Guidelines & Instructions
Limited to a maximum of $200,000, which includes direct costs and a maximum overhead of $19,982 or 11.1 percent of direct costs per year for three years. Budget requests must be carefully justified and commensurate with the project's needs.
Grants are eligible for an additional two years if they include an approved clinical trial and a fully justified research plan. One of the program's principal intents is to permit the acquisition of sufficient data to apply to an appropriate agency or sponsor for sustained support.
|Letter of Intent – open||December 3, 2015|
|Letter of Intent – close||January 25, 2016||3:00PM Eastern Time|
|Full Application – close||March 1, 2016||3:00PM Eastern Time|
How to Apply
LLS uses its own Research Portal powered by FLUXX for electronic preliminary and full application submission.
- Before you submit your letter of intent and application, download and read TRP Guidelines & Instructions for New or Renewal Letter of Intent & Full Application.
- Submit an online letter of intent via FLUXX by 3 p.m. ET, date TBD
- Submit a full online application via FLUXX by 3 p.m. ET, date TBD
If you submitted a proposal and developed a profile with LLS in the past, you (and your institution) still need to validate your account and create a new password in FLUXX. If you have any technical difficulties with FLUXX, please contact us via e-mail at email@example.com.
Need More Information?
Director of Research Administration
The Leukemia & Lymphoma Society
1311 Mamaroneck Ave.
White Plains, NY 10605